SKI Market

A+| A| A-|

Indian Indices

Sensex

78,180.72 -104.35
( -0.13%)

Global Indices

Nasdaq

53,071.47 150.40
(0.28%)

Dow Jones

7,557.54 53.30
(0.71%)

Hang Seng

68,399.59 -1,338.10
(-1.92%)

Nikkei 225

10,649.07 -29.96
(-0.28%)

Forex

USD-INR

95.19 -0.09
(-0.09%)

EUR-INR

108.86 0.10
(0.10%)

GBP-INR

127.02 0.03
(0.03%)

JPY-INR

0.59 0.00
(-0.02%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Zenotech Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532039

INE486F01012

15.5857255

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

280.44

EPS(TTM)

Face Value()

Div & Yield %

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	43.05	40.83	42.42	36.57	22.45	26.02
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	43.05	40.83	42.42	36.57	22.45	26.02
Other Income	3.47	1.00	1.08	0.63	0.41	7.54
Stock Adjustments	0.00	0.00	0.00	0.00	0.00	0.00
Total Income	46.52	41.83	43.50	37.20	22.86	33.56
EXPENDITURE :
Raw Materials	0.84	0.00	0.06	0.00	0.03	0.50
Power & Fuel Cost	2.71	2.69	3.79	3.25	3.12	3.29
Employee Cost	12.38	9.46	7.88	7.10	6.49	5.76
Other Manufacturing Expenses	9.52	8.70	7.67	6.66	4.67	5.61
Selling & Administrative Expenses	2.85	2.33	2.00	1.91	1.62	1.75
Miscellaneous Expenses	0.57	0.43	0.31	0.19	0.13	0.12
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	28.87	23.61	21.72	19.10	16.06	17.04
Operating Profit	17.65	18.23	21.79	18.09	6.79	16.52
Interest	0.00	0.00	0.11	1.22	1.55	0.89
Gross Profit	17.65	18.23	21.68	16.87	5.24	15.63
Depreciation	6.96	7.09	7.17	6.97	6.46	4.85
Profit Before Tax	10.69	11.14	14.51	9.90	-1.22	10.78
Tax	2.49	0.00	0.00	0.00	0.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	2.59	2.84	2.92	-12.27	0.00	0.00
Reported Net Profit	5.61	8.30	11.59	22.18	-1.22	10.78
Extraordinary Items	1.12	-0.03	0.03	0.00	0.00	6.37
Adjusted Net Profit	4.49	8.33	11.56	22.18	-1.22	4.41
Adjustment below Net Profit	-0.02	-0.03	0.04	0.06	-0.01	-0.05
P & L Balance brought forward	-180.03	-188.30	-199.93	-222.17	-220.94	-231.68
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	-174.44	-180.03	-188.30	-199.93	-222.17	-220.94
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	0.92	1.36	1.90	3.63	-0.20	1.77
Earnings Per Share(Adj)-Unit Curr	0.92	1.36	1.90	3.63	-0.20	1.77
Book Value-Unit Curr	15.75	14.84	13.48	11.57	7.93	8.13
Book Value(Adj)-Unit Curr	15.75	14.84	13.48	11.57	7.93	8.13

78,180.72 -104.35 ( -0.13%)

53,071.47 150.40 (0.28%)

7,557.54 53.30 (0.71%)

68,399.59 -1,338.10 (-1.92%)

10,649.07 -29.96 (-0.28%)

95.19 -0.09 (-0.09%)

108.86 0.10 (0.10%)

127.02 0.03 (0.03%)

0.59 0.00 (-0.02%)